164 related articles for article (PubMed ID: 8836913)
1. The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon.
Blatt LM; Davis JM; Klein SB; Taylor MW
J Interferon Cytokine Res; 1996 Jul; 16(7):489-99. PubMed ID: 8836913
[TBL] [Abstract][Full Text] [Related]
2. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
[TBL] [Abstract][Full Text] [Related]
3. [Interferon alfacon-1 (Advaferon): a novel synthetic interferon for the treatment of hepatitis C, its pharmacological and clinical profile].
Yasuda S; Miyata K
Nihon Yakurigaku Zasshi; 2002 Dec; 120(6):421-6. PubMed ID: 12528473
[TBL] [Abstract][Full Text] [Related]
4. Creation of interferon-alpha8 mutants with amino acid substitutions against interferon-alpha receptor-2 binding sites using phage display system and evaluation of their biologic properties.
Yamamoto K; Taniai M; Torigoe K; Yamamoto S; Arai N; Suemoto Y; Yoshida K; Okura T; Mori T; Fujioka N; Tanimoto T; Miyata M; Ariyasu H; Ushio C; Fujii M; Ariyasu T; Ikeda M; Ohta T; Kurimoto M; Fukuda S
J Interferon Cytokine Res; 2009 Mar; 29(3):161-70. PubMed ID: 19196068
[TBL] [Abstract][Full Text] [Related]
5. The design and recombinant protein expression of a consensus porcine interferon: CoPoIFN-α.
Huang L; Cao RB; Wang N; Liu K; Wei JC; Isahg H; Song LJ; Zuo WY; Zhou B; Wang WW; Mao X; Chen PY
Cytokine; 2012 Jan; 57(1):37-45. PubMed ID: 22088600
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of interferon-consensus 1, interferon-alpha 2a, and interferon-beta 1b on HLA expression and lymphoproliferation: a preclinical model for treatment of multiple sclerosis.
Dhib-Jalbut S; Jiang H; Xia Q; Blatt L; Johnson KP; Hilt D
J Interferon Cytokine Res; 1996 Mar; 16(3):195-200. PubMed ID: 8697141
[TBL] [Abstract][Full Text] [Related]
7. Auto-induction expression of human consensus interferon-alpha in Escherichia coli.
EL-Baky NA; Linjawi MH; Redwan EM
BMC Biotechnol; 2015 Mar; 15():14. PubMed ID: 25886839
[TBL] [Abstract][Full Text] [Related]
8. Biologic activities of natural and synthetic type I interferons.
Pfeffer LM
Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-63-S9-69. PubMed ID: 9208874
[TBL] [Abstract][Full Text] [Related]
9. Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon.
Walter MR; Bordens R; Nagabhushan TL; Williams BR; Herberman RB; Dinarello CA; Borden EC; Trotta PP; Pestka S; Pfeffer LM
Cancer Biother Radiopharm; 1998 Jun; 13(3):143-54. PubMed ID: 10850350
[TBL] [Abstract][Full Text] [Related]
10. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.
Pfeffer LM; Dinarello CA; Herberman RB; Williams BR; Borden EC; Bordens R; Walter MR; Nagabhushan TL; Trotta PP; Pestka S
Cancer Res; 1998 Jun; 58(12):2489-99. PubMed ID: 9635566
[TBL] [Abstract][Full Text] [Related]
11. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
Keeffe EB; Hollinger FB
Hepatology; 1997 Sep; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
[TBL] [Abstract][Full Text] [Related]
12. Cell surface binding characteristics correlate with consensus type I interferon enhanced activity.
Klein SB; Blatt LM; Taylor MW
J Interferon Cytokine Res; 1996 Jan; 16(1):1-6. PubMed ID: 8640445
[TBL] [Abstract][Full Text] [Related]
13. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
[TBL] [Abstract][Full Text] [Related]
14. Comparison of an antiviral activity of recombinant consensus interferon with recombinant interferon-alpha-2b.
Koyama AH; Arakawa T; Adachi A
Microbes Infect; 1999 Nov; 1(13):1073-7. PubMed ID: 10572309
[TBL] [Abstract][Full Text] [Related]
15. Type I interferons: ancient peptides with still under-discovered anti-cancer properties.
Caraglia M; Dicitore A; Marra M; Castiglioni S; Persani L; Sperlongano P; Tagliaferri P; Abbruzzese A; Vitale G
Protein Pept Lett; 2013 Apr; 20(4):412-23. PubMed ID: 23016588
[TBL] [Abstract][Full Text] [Related]
16. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
Khine AA; Lingwood CA
J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
[TBL] [Abstract][Full Text] [Related]
17. Amino acid substitutions in loop BC and helix C affect antigenic properties of helix D in hybrid IFN-alpha21a/alpha2c molecules.
Schmeisser H; Hu R; Kontsek P; Bekisz J; Zoon K
J Interferon Cytokine Res; 2002 Apr; 22(4):463-72. PubMed ID: 12034029
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the in vitro host range of recombinant met-interferon-con1, interferon-alpha 2b, and interferon-beta [corrected].
Hu CJ; Ozes ON; Klein SB; Blatt LM; Taylor MW
J Interferon Cytokine Res; 1995 Mar; 15(3):231-4. PubMed ID: 7584668
[TBL] [Abstract][Full Text] [Related]
19. New developments in interferon therapy.
Tossing G
Eur J Med Res; 2001 Feb; 6(2):47-65. PubMed ID: 11313191
[TBL] [Abstract][Full Text] [Related]
20. Cloning and biologic activities of a bovine interferon-alpha isolated from the epithelium of a rotavirus-infected calf.
Chaplin PJ; Entrican G; Gelder KI; Collins RA
J Interferon Cytokine Res; 1996 Jan; 16(1):25-30. PubMed ID: 8640447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
